Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Signifor 0.9mg°


Contraindicated
Reproductive toxicity in animals

Contraindicated
Signifor 0.9mg° :
Type Medicine Withdrawn
Originator B
Agent Mectapharm
Distributor Mectapharm
Laboratory Novartis
Responsible Party Novartis Pharma AG
Origin Switzerland
Manufacturer Novartis Pharma Stein AG
Origin Switzerland
ATC H01CB05

Your comment will appear shortly after approval

Signifor 0.9mg° :

Revision Date : 19/11/2014


Effect Frequency
Abdominal pain Very Common
Abdominal pain upper Common
Adrenal insufficiency Common
Alopecia Common
ALT increased Common
Amylase increased Common
Anaemia Common
Arthralgia (Pain joint) (Joint ache) Common
Blood bilirubin increased Not known
Blood glucose increased Common
Cholelithiasis (Calculus biliary) (Gallstones) Very Common
Decreased appetite Common
Diabetes mellitus Very Common
Diarrhoea (Diarrhea) Very Common
ECG QT prolonged Common
Fatigue Very Common
Gamma-GT increased Common
Glycosylated haemoglobin increased Very Common
Headache Common
Hyperglycaemia Very Common
Hypotension Common
Injection site erythema Not known
Injection site haematoma Not known
Injection site haemorrhage Not known
Injection site pain Not known
Injection site pruritus Not known
Injection site reaction Very Common
Ketoacidosis Not known
Ketosis Not known
Lipase increased Common
Myalgia Common
Nausea Very Common
Pancreatitis Not known
Prothrombin time prolonged Common
Pruritus Common
Sinus bradycardia Common
Type 2 diabetes mellitus Common
Vomiting Common

Different Units By MoH Code

Revision Date : 01/08/2013

Signifor 0.9mg°  MoH 7655 :
Form Solution for injection
Packaging Ampoules (Type I Glass)
Package Size 30x1ml
Strength 0.9mg
Storage Condition <30°C protect from light
NSSF ✘
Quarantine ✔
Reg. Number 222918/14
Submission date 01/01/2014
Registration Year 2014
Withdrawn Date 13/06/2024


Price Comparison

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info